Recall: Greenstone LLC Diphenoxylate Hydrochloride And Atropine Sulfate Tablets, USP
On 2017-11-16, the FDA announced that Greenstone , a wholly owned subsidiary of Pfizer is conducting a recall on Diphenoxylate Hydrochloride And Atropine Sulfate Tablets, USP due to a possible . The recalled products were sold under the brand name(s) Greenstone LLC during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential unintended use, including tri-ton dietary supplement, various herbal and dietary supplements and more. Additionally, there have been 18 drug and medical device recalls due to other health hazards as well as 118 food recalls.
Company Contact Information:
Name: Greenstone , a wholly owned subsidiary of Pfizer
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: diphenoxylate hydrochloride and atropine sulfate tablets, USP
Brand Name(s): Greenstone LLC
Reason for Recall: Sub Potent and Super Potent Tablets
Official Recall Date: 2017-11-16
Additional information provided by the FDA.gov:
Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the potential to be super potent or sub potent. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.